glp-1 blood clots Can Glucagon-like peptide-1 (GLP-1) receptor agonists cause thrombosis (blood clots)? April 2025 PEP Talk: Weight,
Description
You administer one subcutaneous injection every seven days, allowing predictable medication routines that fit seamlessly into weekly schedules
The optimal dosing, duration of treatment, patient selection criteria, and long-term efficacy and safety for this potential indication are unknown
Treatment with liraglutide, a glucagon-like peptide-1 analogue, improves effectively the skin lesions of psoriasis patients with type 2 diabetes: A prospective cohort study
In addition, it will decrease cardiovascular and diabetes risks
Practically, that means: Start extremely low sometimes at one-tenth or one-fifth of the usual initial dose
3 They are useful add-on therapies to attenuate motor fluctuations in patients treated with carbidopa/levodopa
